Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours

Linvoseltamab induces deep and durable responses in patients with relapsed or refractory multiple myeloma

Autovaccination with the intratumoral viral mimic poly-ICLC makes a cold tumour hot in prostate cancer

Avelumab combined with regorafenib shows improved outcome in solid tumours with tertiary lymphoid structures

Darolutamide, androgen-deprivation therapy and docetaxel demonstrate promising efficacy mHSPC

Blood test may identify patients with non-small cell lung cancer subtype who can benefit from combination therapy

Mirvetuximab soravtansine and pembrolizumab combo shows promise in endometrial cancer subtype

Urinary markers in the surveillance setting of non-muscle invasive bladder cancer

Chemo-immunotherapy combo nivolumab and nab-paclitaxel could be effective perioperative strategy for MIBC

EAU 2024: Bladder cancer latest

Pembrolizumab improves breast cancer outcomes regardless of age or menopausal status

Exercise positively effects symptom burden and quality of life of metastatic breast cancer patients